
idkmanimao
Gold
- Joined
- Feb 20, 2025
- Posts
- 792
- Reputation
- 322
1. Nose Height (Dorsal and Tip Projection)
Natural
- None with clinically meaningful effect.
Despite folklore about nasal “exercises” or massage, no controlled studies demonstrate permanent heightening or projection changes without implants or grafts.
Unnatural
- Augmentation Rhinoplasty (Surgical)
- Implant materials: expanded‑PTFE (ePTFE), autologous costal cartilage (ACC), silicone, porous polyethylene.
- Efficacy: In a series of 244 patients, dorsal height increased by 2.64 % with ePTFE and 5.82 % with ACC implants (both p < .001), with high aesthetic‑satisfaction scores Liebert Publications.
- Dorsal Preservation Rhinoplasty
- Preserves the native dorsum while subtly lowering humps and augmenting radix, with an average 4.4 mm hump reduction and 95.6 % aesthetic improvement rate Lippincott Journals.
- Injectable Filler (“Liquid Rhinoplasty”)
- Hyaluronic acid (HA): small volume injections can raise the radix and smooth profile.
- Study: HA augmentation raised dorsal height by ~2 mm on average and was well tolerated in 30 patients over 6 months (no serious adverse events) ScienceDirect.
2. Lips: Thinner (Volume Reduction) & Wider (Horizontal Spread)
Natural
- None proven for structural thinning or widening.
Topical plumping (“lip scrubs,” cinnamon oil) only cause transient vasodilation—no lasting change in vermilion height or width.
Unnatural
- Volume Reduction
- Lip Reduction Surgery: excisional vermilionectomy—removes excess red lip tissue for thinner lips. High patient satisfaction in small series; permanent effect.
- Horizontal Widening
- V‑Y Lip Advancement Flap (for width): local flap techniques can increase horizontal span by ~3–5 mm per side; case reports show reliable outcomes.
- Injectable Fillers
- Thinner effect (contour refinement): low‑volume HA injections into lip borders can sharpen vermilion line.
- Evidence: In a randomized, evaluator‑blinded trial (n=16), Restylane Kysse and Juvéderm Volbella provided durable contouring with >89 % of subjects having ≥1‑grade improvement in fullness or definition at 12 weeks PMC.
- Lip Augmentation (for fullness and slight widening)
- HA gels are well tolerated and durable when used for upper‑lip augmentation PMC.
3. Chin: Broader, More Projected
Natural
- None reliably change bony projection.
Chewing‑based programs (e.g., gum) increase bite force but do not alter mandibular shape or masseter hypertrophy in healthy adults PubMed.
Unnatural
- Sliding Genioplasty (Osteotomy)
- Horizontal osteotomy advances the chin bone forward by 2–6 mm; stable long‑term projection in large series.
- Alloplastic Chin Implants
- Porous polyethylene (Medpor), silicone:
- In a 46‑patient series using porous polyethylene with screw fixation, anatomically correct, stable contours were achieved in both primary and secondary cases PubMed.
- Porous polyethylene (Medpor), silicone:
- Injectable Fillers for Chin
- HA fillers (e.g., Restylane Defyne, Juvéderm Voluma XC): offer a 1–2 mm forward projection with immediate results lasting 9–18 months Allure.
4. Eyes: Crease, “Openness,” Puffiness
Natural
- Lifestyle & Topicals
- Sleep, hydration, salt reduction: reduce transient puffiness but do not alter lid fold or bone.
- Caffeine‑containing eye creams: modestly decrease periorbital edema (small controlled trials), but effects wash out within hours.
Unnatural
- Upper Blepharoplasty (Double‑Eyelid Surgery)
- Incisional or suture methods create a permanent crease.
- Safety & Efficacy: In 86 Asian patients, a novel pretarsal‑OOM release technique yielded a high satisfaction rate with minimal complications PubMed.
- Lower Blepharoplasty
- Removes or re‑drapes fat pads, tightens skin; long‑term reduction in under‑eye bags.
- Canthoplasty/Canthopexy
- Lateral corner tightening to “open” the eye aperture; reliable in orbital‑fat repositioning cases.
- Injectable Approaches
- Tear‑trough Fillers (HA, calcium hydroxyapatite): correct hollowing under the eye with >80 % patient satisfaction at 6 months in small cohorts.
- Pharmacologic
- Oxymetazoline ophthalmic drops (Upneeq): FDA‑approved for acquired ptosis to lift the upper lid by ~1 mm on average in clinical trials.